Its because of a complaint filed with the SEC by Hand and other investors about VitaminSpice imposing a stop transfer on their stock certificates. After that, Bukstel issued about 60 million shares to "consultants." Some investors in 2009 and 2010 paid for stock and Bukstel refused to give it to them and this really got the SEC's attention.
The investigation started in March 2011. It focused on shares issued to the "consultants" and the lawsuit filed by the investors against Bukstel and VitaminSpice. If you look at the PR put out by VitaminSpice from October 2010 to February 2011 and compare this to the financial statements, you will understand the stop trade. The credit line to help fill "backlog" that did not exist, the $5 million order that never happened, compared to the $697 in sales for the March 31, 2011 quarter and the $17 in sales for the June 2011 quarter, its all there.
